1. Research on the repair mechanism of stem cells and renal injury;
2. Molecular pathogenesis of renal development and congenital renal diseases;
Member of clinical precision medical professional committee of Chinese doctors association
National natural science foundation project review expert
Medical doctor, postdoc, associate professor of kidney disease and kidney disease of the PLA general hospital, postgraduate tutor, Beijing science and technology nova. From 2005 to 2010, he completed five years of postdoctoral research at Harvard University and Boston university. In 2010, he joined the PLA general hospital for renal diseases as a recruit. Long-term acute and chronic renal disease precision diagnosis and treatment of renal development and congenital genetic kidney disease molecular pathogenesis diagnosis has been further studied. By gene sequencing and molecular omics, nephrosis pathogenic gene screening, identification of refractory nephrotic syndrome at the individual level and hereditary kidney disease clinical heterogeneity progress mechanism, evaluate the biological response of the treatment, clinical medical guidance precision, improve the prognosis of patients. At home and abroad cooperation has published more than 50, including SCI full text of more than 30 papers, published in Cell ZiKan Cell Report on papers about kidney cells, etc have been respectively by SCI he 27 times, and was The famous magazine is The Journal of Cell biology, Nephrol Dial Transplant references, etc. Five years of editorial work. As the project leader, undertake a national key research and development project (engineering kidney construction based on the physical structure and development of micro-environment); As the main academic backbone, participated in the national key research and development project (the molecular network of the rehabilitation of physiological and pathological rehabilitation after organ damage); National key basic research and development plan "973" project 2 (research on key links of kidney development and key regulatory factors in mammals); Pig induced pluripotent stem (iPS) model with miniature pig disease -- based on iPS cells of pig disease model created 2011 cba01003), as a research project and bear the national natural science fund project 3 items and Beijing topic 2 items.